Angion Biomedica Corp.
ANGNNASDAQHealthcare
$1.00
+$0.00(+0.00%)
Market Cap$30113700
P/E Ratio—
52W High$20.4
52W Low$1.0
Angion Biomedica Corp. (ANGN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ANGN · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 13, 2023EPS Actual
-$1.27
Revenue
—
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 13, 2023
After Market Close
ANGN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 8, 2024 | — | — | — | — | — | — |
| — Q4 FY2023 | Nov 13, 2023 | — | -$1.27 | — | — | — | — |
| ▼ Q3 FY2023 | Aug 21, 2023 | $0.57 | -$2.44 | -527.6% | — | — | — |
| ▲ Q2 FY2023 | May 10, 2023 | -$0.54 | -$0.15 | +72.2% | — | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.38 | — | — | — | — |
| ▲ Q4 FY2022 | Nov 14, 2022 | -$0.36 | -$0.21 | +41.7% | — | — | — |
| ▲ Q3 FY2022 | Aug 15, 2022 | -$0.46 | -$0.30 | +34.8% | $0.00B | — | — |
| ▼ Q2 FY2022 | May 16, 2022 | -$0.44 | -$0.48 | -9.1% | $0.00B | $0.00B | +13.2% |
Q2 FY2024
May 8, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
-$1.27
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 21, 2023Miss
EPS Actual
-$2.44
EPS Est.
$0.57
EPS Surpr.
-527.6%
Revenue
—
Q2 FY2023
May 10, 2023Beat
EPS Actual
-$0.15
EPS Est.
-$0.54
EPS Surpr.
+72.2%
Revenue
—
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Nov 14, 2022Beat
EPS Actual
-$0.21
EPS Est.
-$0.36
EPS Surpr.
+41.7%
Revenue
—
Q3 FY2022
Aug 15, 2022Beat
EPS Actual
-$0.30
EPS Est.
-$0.46
EPS Surpr.
+34.8%
Revenue
$0.00B
Q2 FY2022
May 16, 2022Miss
EPS Actual
-$0.48
EPS Est.
-$0.44
EPS Surpr.
-9.1%
Revenue
$0.00B
No analyst estimates available for ANGN.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Nov 13, 2023 | — | $1.00 | — | — |
| ▼ Q3 FY2023 | Aug 21, 2023 | -527.6% | $1.00 | — | — |
| ▲ Q2 FY2023 | May 10, 2023 | +72.2% | $0.81 | $0.84 | +3.70% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.81 | $0.87 | +7.43% |
| ▲ Q4 FY2022 | Nov 14, 2022 | +41.7% | $0.97 | $0.90 | -7.08% |
| ▲ Q3 FY2022 | Aug 15, 2022 | +34.8% | $1.03 | $1.04 | +0.97% |
| ▼ Q2 FY2022 | May 16, 2022 | -9.1% | $1.30 | $1.30 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $2.87 | $2.90 | +1.05% |
Q4 FY2023—
Report Date
Nov 13, 2023
EPS Beat/Miss
—
Price Before
$1.00
Price After
—
Q3 FY2023—
Report Date
Aug 21, 2023
EPS Beat/Miss
-527.6%
Price Before
$1.00
Price After
—
Q2 FY2023+3.70%
Report Date
May 10, 2023
EPS Beat/Miss
+72.2%
Price Before
$0.81
Price After
$0.84
Q4 FY2022+7.43%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.81
Price After
$0.87
Q4 FY2022-7.08%
Report Date
Nov 14, 2022
EPS Beat/Miss
+41.7%
Price Before
$0.97
Price After
$0.90
Q3 FY2022+0.97%
Report Date
Aug 15, 2022
EPS Beat/Miss
+34.8%
Price Before
$1.03
Price After
$1.04
Q2 FY2022+0.00%
Report Date
May 16, 2022
EPS Beat/Miss
-9.1%
Price Before
$1.30
Price After
$1.30
Q4 FY2021+1.05%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$2.87
Price After
$2.90
Avg Beat Reaction-0.80%
Avg Miss Reaction+0.00%
Beat Rate3 / 8 quarters
Largest Move+7.43% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ANGN ends December
Angion Biomedica Corp. (ANGN) most recently reported earnings on November 13, 2023 for Q4 FY2023, posting EPS of $-1.27 (in line with the analyst consensus of —). The next ANGN earnings date is expected around September 1, 2026.
Each quarter, investors track ANGN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ANGN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ANGN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ANGN earnings · 4 questionsAngion Biomedica Corp.'s next earnings report is expected around September 1, 2026. ANGN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ANGN historically reports after market close (AMC).
ANGN earnings datewhen is ANGN earningsANGN next earnings datewhen does ANGN report earningsANGN earnings calendar
▸ Source: FMP · Angion Biomedica Corp. SEC filings · US GAAP · Angion Biomedica Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026